Opinion statement PSMA-PET has been a practice-changing imaging biomarker for the
management of men with PCa. Research suggests improved accuracy over conventional …

Simple Summary Prostate cancer diagnosis and treatment options have rapidly improved
over the last few years. A growing number of publications have moved to front the utilization …

After prostate malignancy diagnosis, precise determination of disease extent are
fundamental steps for tailored made therapy. The earlier the diagnosis of the burden of the …

Radiolabelled small molecules for imaging prostate cancer have rapidly emerged over the
last few years with gallium-68-labelled prostate-specific-membrane-antigen-11 (68Ga …

As precision medicine evolves, the contribution of molecular imaging to the management of
prostate cancer (PCa) patients, especially for Positron Emission Tomography (PET) imaging …

Prostate-specific membrane antigen (PSMA)-targeted PET agents have revolutionized the
care of patients with prostate cancer, supplanting traditional methods of imaging prostate …

Prostate cancer (PCa) is the most common cancer diagnosed in men in most developed
countries and a leading cause of cancer-related morbidity and mortality. Prostate-specific …

Currently, the findings of imaging procedures used for detection or staging of prostate
cancer depend on morphology of lymph nodes or bone metabolism and do not always meet …

Integration of PSMA-targeted PET imaging into the armamentar... : Current Opinion in Urology
Integration of PSMA-targeted PET imaging into the armamentarium for detecting clinically …

Prostate cancer (PCa) is the most common malignancy in men and a major cause of cancer
death. Accurate imaging plays an important role in diagnosis, staging, restaging, detection of …